Gene · 4325
Papers1,529
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,529
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential expression of host oncogenes in human papillomavirus-associated nasopharyngeal and cervical epithelial cancers. | Kaohsiung J Med Sci | 2024 | 39073693 | PubTator, text mining | PubMed |
| Protease expression in the human and rat cumulus-oocyte complex during the periovulatory period: a role in cumulus-oocyte complex migration†. | Biol Reprod | 2024 | 39018235 | PubTator, text mining | PubMed |
| Astrocytoma with high-grade features and MYBL1-MMP16 fusion. | Surg Neurol Int | 2024 | 38974570 | PubTator, text mining | PubMed |
| Circular RNA Circ_0122396 Regulates Human Lens Epithelial Cell Progression by Regulating miR-23a-3p and MMP16 in Age-Related Cataract. | Curr Eye Res | 2024 | 38966002 | PubTator, text mining | PubMed |
| Interplay of clinical biomarkers in allergic asthma diagnosis and severity: A case-control study. | Cell Mol Biol (Noisy-le-grand) | 2024 | 38814233 | PubTator, text mining | PubMed |
| Identifying and validating MMP family members (MMP2, MMP9, MMP12, and MMP16) as therapeutic targets and biomarkers in kidney renal clear cell carcinoma (KIRC). | Oncol Res | 2024 | 38560573 | PubTator, text mining | PubMed |
| CD133 significance in glioblastoma development: in silico and in vitro study. | Eur J Med Res | 2024 | 38448914 | PubTator, text mining | PubMed |
| Eriodictyol inhibits the motility, angiogenesis and tumor growth of hepatocellular carcinoma via NLRP3 inflammasome inactivation. | Heliyon | 2024 | 38317873 | PubTator, text mining | PubMed |
| Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissue. | Nat Commun | 2024 | 38291024 | PubTator, text mining | PubMed |
| Longitudinal plasma proteomics reveals biomarkers of alveolar-capillary barrier disruption in critically ill COVID-19 patients. | Nat Commun | 2024 | 38272877 | PubTator, text mining | PubMed |
| Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells. | Int J Mol Sci | 2024 | 38255982 | PubTator, text mining | PubMed |
| Plasma cell-free DNA hydroxymethylation profiling reveals anti-PD-1 treatment response and resistance biology in non-small cell lung cancer. | J Immunother Cancer | 2024 | 38212123 | PubTator, text mining | PubMed |
| HCC-Related lncRNAs: Roles and Mechanisms. | Int J Mol Sci | 2024 | 38203767 | PubTator, text mining | PubMed |
| Expression Profiles of Matrix Metalloproteinases and Their Inhibitors in Nasal Polyps. | J Inflamm Res | 2024 | 38193041 | PubTator, text mining | PubMed |
| Implanting mechanically reprogrammed fibroblasts for aged tissue regeneration and wound healing. | Aging Cell | 2024 | 38010905 | PubTator, text mining | PubMed |
| DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors. | Neuroendocrinology | 2024 | 37699356 | PubTator, text mining | PubMed |
| The Wnt-dependent and Wnt-independent functions of BCL9 in development, tumorigenesis, and immunity: Implications in therapeutic opportunities. | Genes Dis | 2024 | 37692512 | PubTator, text mining | PubMed |
| Whole-genome sequencing uncovers two loci for coronary artery calcification and identifies ARSE as a regulator of vascular calcification. | Nat Cardiovasc Res | 2023 | 38817323 | PubTator, text mining | PubMed |
| Matrix metalloproteinases as biomarkers and therapeutic targets in colitis-associated cancer. | Front Oncol | 2023 | 38288108 | PubTator, text mining | PubMed |
| Importance of Metalloproteinase Enzyme Group in Selected Skeletal System Diseases. | Int J Mol Sci | 2023 | 38138968 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4325/papers?page=3